Effect of a Family-Based CBT Self-Help Intervention for Adolescents With OCD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-17
SponsorShanghai Mental Health Center

About this trial

The goal of this clinical trial is to learn if self-help book can be used to treat obsessive-compulsive disorder (OCD) in adolescents aged 10 to 17. The main questions it aims to answer are:

Can adolescents and their parents effectively reduce the severity of the obsessive-compulsive symptoms in adolescents who are already stably taking medications through self-help books? What are the characteristics of adolescents who are best suited to use self-help intervention book to treat obsessive-compulsive symptoms?

Researchers will compare the use of a self-help books plus medication with medication alone to see if the combination of the self-help intervention and drug treatment can improve the obsessive-compulsive symptoms of adolescents more effectively.

Participants will:

* Read one chapter of a self-help book and complete the corresponding exercise each week for 12 weeks * Visit the clinic before and after intervention for checkups and tests

Eligibility criteria

Qualifiers

Age between 10 and 17 years

Satisfied with the diagnostic criteria for OCD in DSM-5

16≤CY-BOCS score ≤23

Taking medication stably for 6 weeks

Disqualifiers

Obsessive-compulsive symptoms were too severe to participate in the experiment(CY-BOCS score ≥24)

High risk of suicide

Comorbid brain organic diseases, severe somatic diseases, learning disabilities, autism spectrum disorders, schizophrenia spectrum and other psychotic disorders, bipolar disorder, severe eating disorders, or substance abuse

Completed a Cognitive Behavioral Therapy (CBT) course for OCD within the past 12 months.

Trial design

Treatments tested in this trial

  • conventional medical treatment (TAU)
  • Family-Based Self-help Book for Adolescents with Obsessive-Compulsive Disorder

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators